Autologous Dendritic Cell Vaccine Optimization for Therapy of Patients with Disseminated Malignant Ne
Immunobiological features of the dendritic cells (DC) were studied for the production of DC-vaccine (DCV) optimization. DC were differentiated in vitro in GM-CSF (previously studied concentration 72 ng/ml and IL-4 0–45 ng/ml containing medium. GM-CSF compounds by Pharmsynthez (Russia) and Cell Genix...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2016-02-01
|
Series: | Sibirskij Onkologičeskij Žurnal |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/131 |